SNDXSyndax Pharmaceuticals, Inc.
$16.99+15% 1Y
$16.99
$13.1152 weeks$25.15
Is the price fair?
What SNDX's price assumes
Syndax Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 6.96× revenue.
6.96
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 116
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 6.17
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 116
- EV / EBIToperating margin −77%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 6.17
- Market capitalisation
- $1.76B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.